KSC Equity Snapshot
128940 Weekly Equity Report
Hanmi Pharm. Co., Ltd.
What the company does
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is …
What the weekly tape is saying
128940 closed the latest completed week at 411,000 KRW. The 4-week return is -13.0% and the 12-week return is -26.3%. Trend Signal is inactive, Market Dynamics is -0.88. Setup signature: Risk-first tape with a 22/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 489,003 KRW
- Vs Trend Line
- -16.0%
- Fair Value
- 335,044 KRW
- Vs Fair Value
- 22.7%
- 52W High
- 644,643 KRW
- 52W Low
- 266,526 KRW
- Drawdown
- -36.2%
- Range Position
- 38.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 46
- 52W Active Breadth
- 88.5%
- Sector Scope
- KR Healthcare
- Sector Rank
- 62 of 63
- Sector Percentile
- 1.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 34 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 23 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.88
- 4W MD Change
- 24.2%
- Relative Strength
- -45.07
- 4W RS Change
- -31.1%
- Expectation
- Positive
- Probability
- 56.93%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 706.0K
- 13W Average
- 607.6K
- 52W Average
- 569.5K
- Vs 13W
- 1.2x
- Vs 52W
- 1.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.9%
- 52W Volatility
- 7.3%
- Upside Weeks
- 27
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 6.2% / -5.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 6834.6B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 411,000 KRW | -16.8% | 489,003 KRW | 335,044 KRW | -0.88 | -45.07 | 706.0K | Off |
| 5 Jun 2026 | 494,000 KRW | 0.6% | 491,012 KRW | 334,385 KRW | -0.75 | -34.99 | 1.9M | Off |
| 29 May 2026 | 491,000 KRW | 8.1% | 489,125 KRW | 333,210 KRW | -0.99 | -38.34 | 604.1K | Off |
| 22 May 2026 | 454,000 KRW | -3.9% | 486,874 KRW | 331,971 KRW | -1.13 | -39.14 | 644.6K | Off |
| 15 May 2026 | 472,500 KRW | 8.4% | 482,999 KRW | 330,903 KRW | -1.16 | -34.38 | 839.9K | Off |
| 8 May 2026 | 436,000 KRW | -5.2% | 478,740 KRW | 329,710 KRW | -1.19 | -40.07 | 361.7K | Off |
| 1 May 2026 | 460,000 KRW | -7.5% | 475,981 KRW | 328,795 KRW | -1.10 | -28.81 | 346.9K | On |
| 24 Apr 2026 | 497,500 KRW | -6.7% | 472,421 KRW | 327,897 KRW | -0.99 | -22.06 | 447.5K | On |
| 17 Apr 2026 | 533,000 KRW | 6.6% | 468,359 KRW | 326,718 KRW | -0.75 | -12.96 | 415.2K | On |
| 10 Apr 2026 | 500,000 KRW | -1.4% | 461,668 KRW | 325,243 KRW | -0.49 | -13.87 | 461.2K | On |
| 3 Apr 2026 | 507,000 KRW | -7.3% | 454,832 KRW | 324,111 KRW | -0.28 | -5.11 | 321.0K | On |
| 27 Mar 2026 | 547,000 KRW | -2.0% | 448,078 KRW | 322,784 KRW | -0.07 | 1.25 | 414.1K | On |
| 20 Mar 2026 | 557,960 KRW | 12.8% | 439,908 KRW | 320,871 KRW | 0.25 | -2.66 | 440.8K | On |
| 13 Mar 2026 | 494,691 KRW | -3.8% | 430,709 KRW | 318,878 KRW | 0.41 | -8.97 | 647.5K | On |